Table of Contents Global Hepatitis C Drugs Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Hepatitis C Drugs Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Hepatitis C Drugs Segment by Type 1.2.1 Anti-Viral 1.2.2 Immuno-modulators 1.2.3 Others 1.3 Market Analysis by Application 1.3.1 Hospitals 1.3.2 Clinics 1.4 Overview of Global Hepatitis C Drugs Market 1.4.1 Global Hepatitis C Drugs Revenue (2015-2025) 1.4.2 Global Hepatitis C Drugs Production and Capacity (2015-2025) 1.4.3 North America Hepatitis C Drugs Status and Prospect (2015-2025) 1.4.4 Europe Hepatitis C Drugs Status and Prospect (2015-2025) 1.4.5 Japan Hepatitis C Drugs Status and Prospect (2014-2025) 1.4.6 China Hepatitis C Drugs Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Hepatitis C Drugs Industry Impact 1.6.1 How the Covid-19 is Affecting the Hepatitis C Drugs Industry 1.6.2 Hepatitis C Drugs Business Impact Assessment - Covid-19 1.6.3 Market Trends and Hepatitis C Drugs Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Hepatitis C Drugs Market Competition by Manufacturer 2.1 Global Hepatitis C Drugs Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Hepatitis C Drugs Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Hepatitis C Drugs Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Hepatitis C Drugs Manufacturer Market Share 2.5 Top 10 Hepatitis C Drugs Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Hepatitis C Drugs Market 2.7 Key Manufacturers Hepatitis C Drugs Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Hepatitis C Drugs Industry Key Manufacturers 3.1 Gilead sciences 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Gilead sciences Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Gilead sciences News 3.2 Abbvi 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Abbvi Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Abbvi News 3.3 Johnson & Johnson 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Johnson & Johnson Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Johnson & Johnson News 3.4 Merck 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Merck Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Merck News 3.5 Glaxosmithkline 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Glaxosmithkline Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Glaxosmithkline News 3.6 Novartis 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Novartis Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Novartis News 3.7 Bristol-Myers Squibb 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Bristol-Myers Squibb Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Bristol-Myers Squibb News 3.8 Roche 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Roche Hepatitis C Drugs Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Roche News 4 Global Hepatitis C Drugs Market Size Categorized by Regions (2015-2020) 4.1 Global Hepatitis C Drugs Sales Market Share by Region 4.2 Global Hepatitis C Drugs Revenue Market Share by Region (2015-2019) 4.3 Global Hepatitis C Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Hepatitis C Drugs Market Size Detail 4.4.1 North America Hepatitis C Drugs Sales Growth Rate (2015-2020) 4.4.2 North America Hepatitis C Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Hepatitis C Drugs Market Size Detail 4.5.1 Europe Hepatitis C Drugs Sales Growth Rate (2015-2020) 4.5.2 Europe Hepatitis C Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Hepatitis C Drugs Market Size Detail 4.6.1 Japan Hepatitis C Drugs Sales Growth Rate (2015-2020) 4.6.2 Japan Hepatitis C Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Hepatitis C Drugs Market Size Detail 4.7.1 China Hepatitis C Drugs Sales Growth Rate (2015-2020) 4.7.2 China Hepatitis C Drugs Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Hepatitis C Drugs Market Segment by Type 5.1 Global Hepatitis C Drugs Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Hepatitis C Drugs Sales and Market Share by Type (2015-2020) 5.1.2 Global Hepatitis C Drugs Revenue and Market Share by Type (2015-2020) 5.2 Anti-Viral Sales Growth Rate and Price 5.2.1 Global Anti-Viral Sales Growth Rate (2015-2020) 5.2.2 Global Anti-Viral Price (2015-2020) 5.3 Immuno-modulators Sales Growth Rate and Price 5.3.1 Global Immuno-modulators Sales Growth Rate (2015-2020) 5.3.2 Global Immuno-modulators Price (2015-2020) 5.4 Others Sales Growth Rate and Price 5.4.1 Global Others Sales Growth Rate (2015-2020) 5.4.2 Global Others Price (2015-2020) 6 Global Hepatitis C Drugs Market Segment by Application 6.1 Global Hepatitis C Drugs Sales Market Share by Application (2015-2020) 6.2 Hospitals Sales Growth Rate (2015-2020) 6.3 Clinics Sales Growth Rate (2015-2020) 7 Hepatitis C Drugs Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Hepatitis C Drugs Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Hepatitis C Drugs Market Forecast 8.1 Global Hepatitis C Drugs Sales, Revenue Forecast 8.1.1 Global Hepatitis C Drugs Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Hepatitis C Drugs Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Hepatitis C Drugs Price and Trend Forecast (2020-2025) 8.2 Global Hepatitis C Drugs Sales Forecast by Region (2020-2025) 8.2.1 North America Hepatitis C Drugs Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Hepatitis C Drugs Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Hepatitis C Drugs Production, Revenue Forecast (2020-2025) 8.2.4 China Hepatitis C Drugs Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Hepatitis C Drugs Picture Table Global Hepatitis C Drugs Sales by Type Figure Global Sales Market Share of Hepatitis C Drugs by Product Type in 2019 Table Breakdown of Hepatitis C Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Figure Hepatitis C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Anti-Viral Picture Figure Immuno-modulators Picture Figure Others Picture Table Global Hepatitis C Drugs Sales by Application Figure Global Hepatitis C Drugs Sales Market Share by Application in 2019 Figure Hospitals Picture Figure Clinics Picture Table Hepatitis C Drugs Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Hepatitis C Drugs Revenue (Million US$) (2015-2025) Figure Global Hepatitis C Drugs Production (K Units) (2015-2025) Figure North America Hepatitis C Drugs Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Hepatitis C Drugs Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Hepatitis C Drugs Revenue (Million US$) Growth Rate (2014-2025) Figure China Hepatitis C Drugs Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Hepatitis C Drugs Sales by Manufacturer (2018-2020) Figure Global Hepatitis C Drugs Sales Market Share by Manufacturer in 2019 Table Global Hepatitis C Drugs Revenue by Manufacturer (2018-2020) Figure Global Hepatitis C Drugs Revenue Market Share by Manufacturer in 2019 Table Global Hepatitis C Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Hepatitis C Drugs Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Hepatitis C Drugs Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Hepatitis C Drugs Market Table Key Manufacturers Hepatitis C Drugs Product Type Table Mergers & Acquisitions Planning Table Gilead sciences Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Gilead sciences Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Gilead sciences Hepatitis C Drugs Market Share (2018-2020) Table Gilead sciences Main Business Table Gilead sciences Recent Development Table Abbvi Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Abbvi Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Abbvi Hepatitis C Drugs Market Share (2018-2020) Table Abbvi Main Business Table Abbvi Recent Development Table Johnson & Johnson Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Johnson & Johnson Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Johnson & Johnson Hepatitis C Drugs Market Share (2018-2020) Table Johnson & Johnson Main Business Table Johnson & Johnson Recent Development Table Merck Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Merck Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Merck Hepatitis C Drugs Market Share (2018-2020) Table Merck Main Business Table Merck Recent Development Table Glaxosmithkline Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Glaxosmithkline Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Glaxosmithkline Hepatitis C Drugs Market Share (2018-2020) Table Glaxosmithkline Main Business Table Glaxosmithkline Recent Development Table Novartis Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Novartis Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis Hepatitis C Drugs Market Share (2018-2020) Table Novartis Main Business Table Novartis Recent Development Table Bristol-Myers Squibb Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Bristol-Myers Squibb Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Bristol-Myers Squibb Hepatitis C Drugs Market Share (2018-2020) Table Bristol-Myers Squibb Main Business Table Bristol-Myers Squibb Recent Development Table Roche Company Profile Figure Hepatitis C Drugs Product Picture and Specifications of Roche Table Hepatitis C Drugs Production, Price, Revenue and Gross Margin of 2018-2020 Figure Roche Hepatitis C Drugs Market Share (2018-2020) Table Roche Main Business Table Roche Recent Development Table Global Hepatitis C Drugs Sales (K Units) by Region (2015-2020) Table Global Hepatitis C Drugs Sales Market Share by Region (2015-2019) Figure Global Hepatitis C Drugs Sales Market Share by Region (2015-2019) Figure Global Hepatitis C Drugs Sales Market Share by Region in 2018 Table Global Hepatitis C Drugs Revenue (Million US$) by Region (2015-2020) Table Global Hepatitis C Drugs Revenue Market Share by Region (2015-2020) Figure Global Hepatitis C Drugs Revenue Market Share by Region (2015-2020) Figure Global Hepatitis C Drugs Revenue Market Share by Region in 2019 Table Global Hepatitis C Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Hepatitis C Drugs Sales (K Units) Growth Rate (2015-2020) Figure Europe Hepatitis C Drugs Sales (K Units) Growth Rate (2015-2020) Table Europe Hepatitis C Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Hepatitis C Drugs Sales (K Units) Growth Rate (2015-2020) Table Japan Hepatitis C Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Hepatitis C Drugs Sales (K Units) Growth Rate (2015-2020) Table China Hepatitis C Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Hepatitis C Drugs Sales by Type (2015-2020) Table Global Hepatitis C Drugs Sales Market Share by Type (2015-2020) Figure Global Hepatitis C Drugs Sales Market Share by Type in 2019 Table Global Hepatitis C Drugs Revenue by Type (2015-2020) Table Global Hepatitis C Drugs Revenue Market Share by Type (2015-2020) Figure Global Hepatitis C Drugs Revenue Market Share by Type in 2019 Figure Global Anti-Viral Sales Growth Rate (2015-2025) Figure Global Anti-Viral Price (2015-2020) Figure Global Immuno-modulators Sales Growth Rate (2015-2025) Figure Global Immuno-modulators Price (2015-2020) Figure Global Others Sales Growth Rate (2015-2025) Figure Global Others Price (2015-2020) Table Global Hepatitis C Drugs Sales Market Share by Application (2015-2020) Figure Global Hepatitis C Drugs Sales Market Share by Application in 2019 Figure Global Hospitals Sales Growth Rate (2015-2025) Figure Global Clinics Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Hepatitis C Drugs Table Key Players of Downstream Markets Figure Sales Channel Figure Global Hepatitis C Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Hepatitis C Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Hepatitis C Drugs Price and Trend Forecast (2020-2025) Table Global Hepatitis C Drugs Sales (K Units) Forecast by Region (2020-2025) Figure Global Hepatitis C Drugs Production Market Share Forecast by Region (2020-2025) Figure North America Hepatitis C Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Hepatitis C Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Hepatitis C Drugs Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Hepatitis C Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Hepatitis C Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Hepatitis C Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Hepatitis C Drugs Production (K Units) Growth Rate Forecast (2020-2025) Figure China Hepatitis C Drugs Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Gilead sciences Abbvi Johnson & Johnson Merck Glaxosmithkline Novartis